Viewing Study NCT00626860


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-02-03 @ 6:12 AM
Study NCT ID: NCT00626860
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2008-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None melanoma View